1-1 of 1
risk evaluation and mitigation
Close
Sort by
Journal Articles

Fulfillment of Postmarketing Commitments for Novel Malignant Hematology Products Granted Accelerated Approval By the FDA between 2011-2016

Marjorie E Zettler, PhD MPH, Chadi Nabhan, MD MBA, FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4712.
https://doi.org/10.1182/blood.V130.Suppl_1.4712.4712
Published: 2017